X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs STERLING BIOTECH - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS STERLING BIOTECH J.B.CHEMICALS/
STERLING BIOTECH
 
P/E (TTM) x 15.1 -1.8 - View Chart
P/BV x 2.4 0.1 3,484.9% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   STERLING BIOTECH
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
STERLING BIOTECH
Dec-13
J.B.CHEMICALS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs31811 3,029.5%   
Low Rs2003 5,867.6%   
Sales per share (Unadj.) Rs148.026.8 552.0%  
Earnings per share (Unadj.) Rs19.1-15.0 -127.6%  
Cash flow per share (Unadj.) Rs23.9-5.5 -438.4%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.954.9 235.0%  
Shares outstanding (eoy) m84.82267.87 31.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.3 674.6%   
Avg P/E ratio x13.6-0.5 -2,918.4%  
P/CF ratio (eoy) x10.8-1.3 -849.5%  
Price / Book Value ratio x2.00.1 1,584.9%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9511,862 1,179.1%   
No. of employees `0002.71.4 201.9%   
Total wages/salary Rs m1,841547 336.7%   
Avg. sales/employee Rs Th4,590.95,303.3 86.6%   
Avg. wages/employee Rs Th673.4403.8 166.8%   
Avg. net profit/employee Rs Th592.1-2,959.0 -20.0%   
INCOME DATA
Net Sales Rs m12,5517,181 174.8%  
Other income Rs m54243 1,271.4%   
Total revenues Rs m13,0937,223 181.3%   
Gross profit Rs m2,055947 217.0%  
Depreciation Rs m4122,543 16.2%   
Interest Rs m964,377 2.2%   
Profit before tax Rs m2,088-5,931 -35.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469-1,924 -24.4%   
Profit after tax Rs m1,619-4,007 -40.4%  
Gross profit margin %16.413.2 124.1%  
Effective tax rate %22.532.4 69.2%   
Net profit margin %12.9-55.8 -23.1%  
BALANCE SHEET DATA
Current assets Rs m7,77814,335 54.3%   
Current liabilities Rs m4,35849,809 8.7%   
Net working cap to sales %27.2-494.0 -5.5%  
Current ratio x1.80.3 620.1%  
Inventory Days Days55403 13.6%  
Debtors Days Days80171 46.9%  
Net fixed assets Rs m5,71355,432 10.3%   
Share capital Rs m170268 63.3%   
"Free" reserves Rs m10,54713,935 75.7%   
Net worth Rs m10,93714,701 74.4%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m15,57473,988 21.0%  
Interest coverage x22.8-0.4 -6,429.0%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.1 830.4%   
Return on assets %11.00.5 2,197.7%  
Return on equity %14.8-27.3 -54.3%  
Return on capital %20.0-6.4 -310.7%  
Exports to sales %48.725.9 188.1%   
Imports to sales %7.10.2 4,167.4%   
Exports (fob) Rs m6,1151,860 328.8%   
Imports (cif) Rs m88912 7,284.4%   
Fx inflow Rs m6,1691,860 331.7%   
Fx outflow Rs m1,28525 5,163.2%   
Net fx Rs m4,8841,835 266.2%   
CASH FLOW
From Operations Rs m1,3971,719 81.3%  
From Investments Rs m-320-3,148 10.2%  
From Financial Activity Rs m-1,1961,426 -83.9%  
Net Cashflow Rs m-102-3 3,008.8%  

Share Holding

Indian Promoters % 55.4 33.9 163.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.0 -  
FIIs % 3.9 9.9 39.4%  
ADR/GDR % 0.0 16.9 -  
Free float % 37.0 39.3 94.1%  
Shareholders   30,437 21,482 141.7%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 16, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS